These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 3519548)
1. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells. Navarrete C; Fernandez N; Alonso MC; Festenstein H Hum Immunol; 1986 May; 16(1):52-68. PubMed ID: 3519548 [TBL] [Abstract][Full Text] [Related]
2. Gamma-IFN induces a differential expression of HLA-DR, DQ and DP antigens on peripheral blood myeloid leukemic blasts at various stages of differentiation. Lecchi M; Lovisone E; Genetta C; Peruccio D; Resegotti L; Richiardi P Leuk Res; 1989; 13(3):221-6. PubMed ID: 2496277 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells. Pesando JM; Graf L J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141 [TBL] [Abstract][Full Text] [Related]
4. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors. Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268 [TBL] [Abstract][Full Text] [Related]
6. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate. Guy K; Meehan RR; Dewar AE; Larhammar D Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424 [TBL] [Abstract][Full Text] [Related]
7. Distribution of class IIDQ antigens on normal and leukemic lymphoid cells. Fermand JP; Schmitt C; Brouet JC Eur J Immunol; 1985 Dec; 15(12):1183-7. PubMed ID: 3878788 [TBL] [Abstract][Full Text] [Related]
8. Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression. Al-Katib A; Koziner B Br J Haematol; 1984 Jul; 57(3):373-82. PubMed ID: 6378248 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of HLA-DR and HLA-DQ antigens on normal cells of the myelomonocytic lineage. Alonso MC; Navarrete C; Solana R; Torres A; Pena J; Festenstein H Tissue Antigens; 1985 Nov; 26(5):310-7. PubMed ID: 3867176 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression. Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732 [TBL] [Abstract][Full Text] [Related]
11. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies. Stöckbauer P; Malasková V; Soucek J; Chudomel V Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116 [TBL] [Abstract][Full Text] [Related]
12. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479 [TBL] [Abstract][Full Text] [Related]
13. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia. Guy K; Docherty LJ; Dewar AE Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060 [TBL] [Abstract][Full Text] [Related]
14. Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation. Ibisch C; Gallot G; Vivien R; Diez E; Jotereau F; Garand R; Vié H Bone Marrow Transplant; 1999 Jun; 23(11):1153-9. PubMed ID: 10382955 [TBL] [Abstract][Full Text] [Related]
15. T cells specific for different antigens express different HLA-D region products. Schendel DJ; Johnson JP Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791 [TBL] [Abstract][Full Text] [Related]
16. Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses. van Luijn MM; Chamuleau ME; Thompson JA; Ostrand-Rosenberg S; Westers TM; Souwer Y; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA Haematologica; 2010 Mar; 95(3):485-93. PubMed ID: 19903675 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells. Howard DR; Eaves AC; Takei F Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652 [TBL] [Abstract][Full Text] [Related]
18. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells. van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823 [TBL] [Abstract][Full Text] [Related]
19. HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset. Jaraquemada D; Navarrete C; Ollier W; Awad J; Okoye R; Festenstein H Hum Immunol; 1986 Jul; 16(3):259-70. PubMed ID: 2424875 [TBL] [Abstract][Full Text] [Related]
20. Pattern of expression of HLA-DR and HLA-DQ antigens and mRNA in myeloid differentiation. Amatruda TT; Bohman R; Ranyard J; Koeffler HP Blood; 1987 Apr; 69(4):1225-36. PubMed ID: 3103718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]